Claims

Collaborative group assignments for new drug evaluations using CASP achieved average scores above 80%

Claim · All claims
Evidence · 1 study · design r2 · q2
Currency · newest study 2024 · not yet checked against its sources · not reviewed by a person

Subclaims

Reading the evidence codes

q is the design tier, i the impact, n the sample, and the kind with its r the rigour judged within that kind: what each code means.

This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.

q2 i? After individual skill development, students' group tasks evaluating new medications averaged 86.61 ± 6.93%, with a maximum of 100 and minimum of 76.60. → Nawanopparatsakul 2024

Evidence

Nawanopparatsakul 2024

Nawanopparatsakul, S., Watana, S., Taesotikul, T., Phuagphong, P., & Chinpaisal, C. (2024). Development of Skills for Pharmacy Students in Evaluating Randomized Controlled Trials Using CASP Checklist. Proceedings of ICRES 2024 -- International Conference on Research in Education and Science. https://eric.ed.gov/?id=ED673088

q2 · i? · design · r2

Instructor-rubric evaluation of small-team group assignments in which students presented new medications of interest and their CASP assessments, reported in Table 3; the article prints the "average of 86.61 ± 6.93%" with no inferential test.

"Students attained a maximum score of 100%, with an average of 86.61 ± 6.93%. Evaluation of these new medication assignments revealed students' development of professional pharmaceutical evaluation skills in medication assessment post the course's teaching and learning process."

Discussion

Learner Variables

Page metadata
Field Value
status review
generated by process:wiki-ingest on 2026-11-01
trust unverified — no one has confirmed this page's content

Frontmatter is the page's machine-readable record — see the Schema & Guide.